A3N-77624-03511
2 vaccinations
5 coded responses
6 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 404 / KY
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WBA-72245-42115
Child or adolescent in my care · Male · 2021-06-15
A4D-39432-47206
Adult relative or friend · Male · 2021-06-15
W52-30096-82829
Child or adolescent in my care · Male · 2021-06-15
Timeline
-
2021-05-14
Dose 1 — Pfizer-BioNTech
-
2021-06-04
Dose 2 — Pfizer-BioNTech
-
2021-06-15
Registered in v-safe
-
2021-06-15
Survey response — day 7, dose 2MedDRA: Injection site induration, Injection site mass — Feeling: Fair · Site: Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Hard lump at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-18
Survey response — day 14, dose 2MedDRA: Arthralgia, Headache, Myalgia — Feeling: FairFree text: Headache , joint and muscle pain- worse in hip/pelvis and lower extremity but also in upper extremity just not as bad. ChillingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Survey response — day 21, dose 2MedDRA: Arthralgia, Fatigue, Headache, Myalgia, Peripheral swelling — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Swelling of bilateral lower extremities, muscle joint pain, extreme fatigue, ongoing headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-02
-
2021-07-13
Survey response — day 35, dose 2MedDRA: Arthralgia, Myalgia, Nasal congestion, Respiratory tract congestion, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Reappearance of muscle and joint pain, fatigue. (Prevents exercise routine). New symptoms of head/sinus/nasal fullnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-16
Survey response — day 42, dose 2MedDRA: Arthralgia, Headache, Myalgia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Extreme muscle and joint pain , worsening headachesMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-14 | Pfizer-BioNTech | |
| 2 | 2021-06-04 | Pfizer-BioNTech |
Free text
Release 9 — day 7, dose 2
Systemic reaction (other): Hard lump at injection site
Release 9 — day 14, dose 2
Symptoms: Headache , joint and muscle pain- worse in hip/pelvis and lower extremity but also in upper extremity just not as bad. Chilling
Release 9 — day 21, dose 2
Symptoms: Swelling of bilateral lower extremities, muscle joint pain, extreme fatigue, ongoing headache
Release 9 — day 35, dose 2
Symptoms: Reappearance of muscle and joint pain, fatigue. (Prevents exercise routine). New symptoms of head/sinus/nasal fullness
Release 9 — day 42, dose 2
Symptoms: Extreme muscle and joint pain , worsening headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release